Short-term secondary outcomes of a phase 3 RCT (1,103 randomised) in mid and low rectal cancer: transanal TME had fewer conversions than laparoscopic TME (1% vs 17%), with similar 90-day complications (20% vs 18%) and anastomotic leakage (10% vs 8%).
RCTn = 1,103
Tuynman et al. Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial